TY  - JOUR

T1  - Antitumor activity in a randomized phase II study comparing two schedules of NKTR-102 in patients (Pts) with pretreated metastatic breast cancer (MBC).

JO  - Journal of Clinical Oncology

PY  - 2011/05/20

AU  - Awada A

AU  - Chan S

AU  - Jerusalem GHM

AU  - Coleman RE

AU  - Huizing MT

AU  - Mehdi A

AU  - O'Reilly SM

AU  - Hamm JT

AU  - Barrett-Lee PJ

AU  - Cocquyt V

AU  - Sideras K et al

ED  - 

DO  - DOI: 10.1200/jco.2011.29.15_suppl.1034

PB  - American Society of Clinical Oncology (ASCO)

VL  - 29

IS  - 15_suppl

SP  - 1034

EP  - 1034

Y2  - 2025/10/10

ER  -